NOTE 10 – STOCKHOLDERS’ EQUITY

Preferred Stock

The Company has 1,000,000 authorized shares of preferred stock with a par value of $0.001 per share, of which one (1) share has been designated Series X Preferred Stock (the “Series X Preferred Stock”).

In January 2026, the Company issued one (1) share of the Series X Preferred Stock to Harpreet Sangha, its sole officer and director and holder of the majority voting power. While Mr. Sangha held the majority voting power of the Company prior to such issuance, the Board of Directors of the Company deemed it to be in the best interests of the Company and its shareholders to assure stability and continuity during the Company’s initial stages of development to issue the Series X Share to Mr. Sangha.

Common Stock

The Company has 500,000,000 authorized shares of common stock with a par value of $0.001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.

During the three months ended July 31, 2025, the former CEO and Director of the Company, Oleg Bilinski, forgave $137,000 of his related party loan which increased additional paid-in capital by $137,000.

During the year ended April 30, 2026, the Company issued 2,000,000 shares of common stock as a portion of the consideration paid for the acquisition of mining rights pursuant to the Properties Agreement described in Note 5. The Company measured the 2,000,000 shares at the closing market price of the Company’s common stock on January 19, 2026 (the date of the Properties Agreement) of $0.80 per share, in accordance ASC 805-50 (asset acquisitions), resulting in share consideration of $1,600,000 that was capitalized as part of Mining Assets. See Note 5.

During the year ended April 30, 2026, the Company has issued a total of 11,350,000 shares of common stock to various consultants for services rendered. The Company recognized the stock-based compensation for the shares issued based on closing share price on the respective grant dates totaling $13,316,280.

During the year ended April 30, 2026, the Company has issued a total of 45,000 shares of common stock with associated debt agreement. As the shares were issued with debt, the Company recorded a total of $42,003 in interest expense based on the respective closing share price on the grant dates.

At April 30, 2026 and 2025, there were 19,224,047 and 5,829,047 shares of common stock issued and outstanding, respectively.